- Home
- ACHV vs SKIL Comparison
ACHV vs SKIL Comparison
Compare ACHV & SKIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- SKIL
- Stock Information
- Founded
- ACHV N/A
- SKIL 1998
- Country
- ACHV Canada
- SKIL United States
- Employees
- ACHV N/A
- SKIL N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SKIL Computer Software: Prepackaged Software
- Sector
- ACHV Health Care
- SKIL Technology
- Exchange
- ACHV Nasdaq
- SKIL Nasdaq
- Market Cap
- ACHV 149.6M
- SKIL 128.9M
- IPO Year
- ACHV N/A
- SKIL N/A
- Fundamental
- Price
- ACHV $4.33
- SKIL $14.48
- Analyst Decision
- ACHV Strong Buy
- SKIL Strong Buy
- Analyst Count
- ACHV 5
- SKIL 4
- Target Price
- ACHV $14.80
- SKIL $36.67
- AVG Volume (30 Days)
- ACHV 116.0K
- SKIL 30.3K
- Earning Date
- ACHV 11-07-2024
- SKIL 12-03-2024
- Dividend Yield
- ACHV N/A
- SKIL N/A
- EPS Growth
- ACHV N/A
- SKIL N/A
- EPS
- ACHV N/A
- SKIL N/A
- Revenue
- ACHV N/A
- SKIL $536,511,999.00
- Revenue This Year
- ACHV N/A
- SKIL N/A
- Revenue Next Year
- ACHV N/A
- SKIL $3.46
- P/E Ratio
- ACHV N/A
- SKIL N/A
- Revenue Growth
- ACHV N/A
- SKIL N/A
- 52 Week Low
- ACHV $3.03
- SKIL $5.09
- 52 Week High
- ACHV $5.98
- SKIL $20.20
- Technical
- Relative Strength Index (RSI)
- ACHV 40.62
- SKIL 36.72
- Support Level
- ACHV $4.12
- SKIL $13.91
- Resistance Level
- ACHV $4.46
- SKIL $15.02
- Average True Range (ATR)
- ACHV 0.24
- SKIL 0.73
- MACD
- ACHV -0.05
- SKIL -0.15
- Stochastic Oscillator
- ACHV 17.65
- SKIL 22.89
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segment includes Content & Platform and Instructor-Led Training. The Content & Platform business engages in the sale, marketing and delivery of its content learning solutions, in areas such as Leadership and Business, Technology and Developer and Compliance. The Instructor-Led Training business offers training solutions covering information technology and business skills for corporations and their employees. The majority of revenue is from the Content & Platform segment.